Results 61 to 70 of about 513,178 (237)

Antiphospholipid Syndrome

open access: yesRevista Ciências em Saúde, 2019
Antiphospholipid syndrome (APS) was characterized as an autoimmune condition with the production of antiphospholipid antibodies (aPL) associated with thrombosis and morbidity in pregnancy.
Thaís da Silva Santos   +4 more
doaj   +1 more source

Integrative proteomic profiling of extracellular vesicle‐enriched preparations with machine learning identifies disease activity‐associated signatures linked to adverse pregnancy outcomes in systemic lupus erythematosus

open access: yesVIEW, EarlyView.
Integrating cross‐cohort extracellular vesicle proteomics with machine learning identifies a simplified protein signature (AGT, FETUB, SPP2, and FCN3) for adverse pregnancy outcome risk stratification in systemic lupus erythematosus, enabling precise disease‐activity discrimination beyond routine clinical assessment.
Weiwei Shi   +5 more
wiley   +1 more source

Effects of CSF from CNS SLE patients on neuronal calcium signaling

open access: yes, 2023
Online.
Andjus, PR   +4 more
core  

Anticoagulantes Lúpicos versus Anticorpos Antifosfolípidos.

open access: yesActa Médica Portuguesa, 1998
The antiphospholipid antibodies (aPL) present in "antiphospholipid-protein syndrome and autoimmune disorders" are associated with thromboembolic episodes, such as venous and/or arterial thrombosis and fetal loss. Patients with antiphospholipid antibodies
M I Pereira
doaj   +1 more source

Screen‐Detected Coeliac Disease in a Nationally Representative Cohort: Health Indicators, Long‐Term Outcomes and Mortality

open access: yesAlimentary Pharmacology &Therapeutics, EarlyView.
In a nationally representative Finnish cohort, screen‐detected coeliac disease was associated with iron deficiency, anaemia, and an atherogenic lipid profile at diagnosis, but long‐term gluten‐free treatment did not adversely affect quality of life, metabolic health, or mortality; supporting a favourable benefit‐harm balance for population‐based ...
Iida Ahonen   +5 more
wiley   +1 more source

A human monoclonal antiphospholipid antibody that is representative of serum antibodies and is germline encoded

open access: yes, 1995
Objective. To investigate the origins of antiphospholipid antibodies associated with thrombosis and other disorders that are found in patients with systemic lupus erythematosus and primary antiphospholipid syndrome (APS). Methods.
Thompson, K.   +6 more
core   +1 more source

Antiphospholipid Antibodies and Lipids in Hematological Malignancies

open access: yes, 2022
One of the main groups of lipids is phospholipids, which are mainly involved in forming cell membranes. Neoplastic processes such as cell replication have increased lipid synthesis, making tumor cells dependent on this synthesis to maintain their ...
Sinaí-del-Carmen Rodríguez-Dávila   +7 more
core   +1 more source

Etanercept and venous thromboembolism: a case series

open access: yesJournal of Medical Case Reports, 2010
Introduction The treatment with antitumor necrosis factor agents has often been associated with the induction of autoantibodies (antinuclear antibodies, anti-double stranded DNA antibodies and antiphospholipid antibodies).
Guggenheim Carla   +3 more
doaj   +1 more source

Origin and pathogenesis of antiphospholipid antibodies

open access: yesBrazilian Journal of Medical and Biological Research, 1998
Antiphospholipid antibodies (aPL) are a heterogeneous group of antibodies that are detected in the serum of patients with a variety of conditions, including autoimmune (systemic lupus erythematosus), infectious (syphilis, AIDS) and lymphoproliferative ...
C.M. Celli, A.E. Gharavi
doaj   +1 more source

Home - About - Disclaimer - Privacy